Month: November 2022

Pal, Ashutosh published an article in 2021, the title of the article was Synthesis of salicylate and salicylamide alcohols for the preparation of phosphorodiamidates and ifosfamide prodrugs.COA of Formula: C13H10O3 And the article contains the following content:

Different types of salicylate and salicylamide alcs. for the preparation of phosphorodiamidates and ifosfamide prodrugs were reported. In drug discovery and development, prodrugs were well-known for pharmacokinetic effects of pharmacol. nimble products. Almost 10% of drugs permitted, whole world were classified as prodrugs, where the application of a prodrug method during initial stages of development was an emergent fashion. The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).COA of Formula: C13H10O3

The Article related to hydroxyalkyl benzodioxinone preparation, aldehyde salicylate alc cyclocondensation, alkyl benzoxazinone preparation, salicylamide aldehyde cyclocondensation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazines (Including Morpholine) and other aspects.COA of Formula: C13H10O3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 26, 2020, Takemura, Hiroyuki; Morikawa, Akino; Tanaka, Mari; Tatsumi, Akane; Kubota, Yukiko; Kaji, Natsuko; Hasegawa, Ayako; Kumamoto, Fumiko; Obara, Tomoko; Iwanaga, Tetsuo; Sako, Katsuya published an article.SDS of cas: 118-55-8 The title of the article was Syntheses of diaza(hetera)2[1.1.1.1]paracyclophanes by Chapman rearrangement. And the article contained the following:

Diaza(hetera)2[1.1.1.1]paracyclophanes (PCPs) I (X = SO2, CH2; Y = SO2; Q = NH) were prepared by the Chapman rearrangement. This is the first synthesis of highly strained and heteroatom-containing PCPs performed by a rearrangement reaction. The structures of the two precursors, [3.1.3.1]PCPs, e.g., II and [1.1.1.1]PCPs I (X = SO2, CH2, C=O; Y = SO2, C=O; Q = N-C(=O)-o-C6H4-OH), are discussed in detail. In contrast to the small strain of [3.1.3.1]PCPs, e.g., II, [1.1.1.1]PCPs I (Q = N-C(=O)-o-C6H4-OH) release their large strain by bending the aromatic rings and Carom.-X angles. Interestingly, Aromatic-X-Aromatic angles are smaller than those of the corresponding strain-free model compounds The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).SDS of cas: 118-55-8

The Article related to diaza hetera paracyclophane preparation, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.SDS of cas: 118-55-8

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 31, 2015, Stead, Darren; O’Brien, Peter; Sanderson, Adam published an article.Name: tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate The title of the article was Investigation of the Lithiation-Trapping of an N-BOC Bispidine-Ketal: Reactivity and Diastereoselectivity. And the article contained the following:

The lithiation-trapping of an N-BOC bispidine-ketal using BuLi/TMEDA has been studied. Key findings include an activating effect of the 4-ketal group on the lithiation and complete diastereoselectivity with methylation and Cu-mediated allylation. In contrast, reduced diastereoselectivity was noted for direct allylation and silylation; mechanistic explanations are proposed. The synthesis of the target compounds was achieved using 7-(phenylmethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxylic acid 1,1-dimethylethyl ester (i.e., a bispidine carboxylic acid ester derivative), 9-oxo-7-(phenylmethyl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxylic acid 1,1-dimethylethyl ester (i.e., a bispidine-ketone derivative), 7-(phenylmethyl)Spiro[3,7-diazabicyclo[3.3.1]nonane-9,2′-[1,3]dioxolane]-3-carboxylic acid 1,1-dimethylethyl ester (i.e., a cyclic-ketal-bispidine derivative) as starting materials. The title compounds thus formed included bispidine-diastereomer derivatives, such as (1R,2S,5S)-rel-7-(phenylmethyl)-2-(2-propen-1-yl)-3,7-diazabicyclo[3.3.1]nonane-3-carboxylic acid 1,1-dimethylethyl ester. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Name: tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

The Article related to lithiation bispidine ketal diastereoselectivity, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.Name: tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 24, 1999, Strandlund, Gert; Alstermark, Christer; Bjore, Annika; Bjorsne, Magnus; Frantsi, Marianne; Halvarsson, Torbjorn; Hoffmann, Kurt-Jurgen; Lindstedt, Eva-Lotte; Polla, Magnus published a patent.HPLC of Formula: 227940-70-7 The title of the patent was Preparation of 3,7-diazabicyclo[3.3.1]nonane-3-carboxylates as antiarrhythmic agents. And the patent contained the following:

Title compounds [I; R1,R2 = H or alkyl; R1R2 = OCH2CH2O, (CH2)4-5; R3 = CCR10R11AR; A = bond, alkylene, (CH2)nZ, CONR20, etc.; B = bond, alkylene, NR23(CH2)r, O(CH2)r; R = (un)substituted Ph; R4 = COXR9; R9 = alkyl, (un)substituted phenyl(alkyl), -naphthyl; R10 = H or OH; R11,R20,R23 = H or alkyl; X = O or S; Z = NR20, SO0-2, O; n,r = 0-4] were prepared Thus, 4-(NC)C6H4OH was condensed with epichlorohydrin and the product aminated by I (R1 = R2 = H, R4 = CO2CMe3)(II; R3 = H)(preparation given) to give II [R3 = CH2CH(OH)CH2OC6H4(CN)-4]. Data for biol. activity of I were given. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).HPLC of Formula: 227940-70-7

The Article related to diazabicyclononanecarboxylate preparation antiarrhythmic agent, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.HPLC of Formula: 227940-70-7

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On May 2, 2006, Baldwin, John J.; Tran, Vinh D. published a patent.HPLC of Formula: 227940-70-7 The title of the patent was Preparation of a diazabicyclononane scaffold which is useful in for combinatorial synthesis. And the patent contained the following:

Diazabicyclononanes [I; A = CHNHR1; R1 = H, residue of a solid substrate; R2 = H, amino-protecting group; with the proviso that no more than one of R1, R2 and R3 is H; e.g., II] and their synthesis are described and are useful as scaffolds for constructing combinatorial libraries. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).HPLC of Formula: 227940-70-7

The Article related to diazabicyclononane preparation scaffold combinatorial synthesis, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.HPLC of Formula: 227940-70-7

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Loew, Henrik; Mena-Osteritz, Elena; von Delius, Max published an article in 2018, the title of the article was Self-assembled orthoester cryptands: orthoester scope, post-functionalization, kinetic locking and tunable degradation kinetics.Synthetic Route of 707-07-3 And the article contains the following content:

Dynamic adaptability and biodegradability are key features of functional, 21st century host-guest systems. We have recently discovered a class of tripodal supramol. hosts, in which two orthoesters act as constitutionally dynamic bridgeheads. Having previously demonstrated the adaptive nature of these hosts, we now report the synthesis and characterization – including eight solid state structures – of a diverse set of orthoester cages, which provides evidence for the broad scope of this new host class. With the same set of compounds, we demonstrated that the rates of orthoester exchange and hydrolysis can be tuned over a remarkably wide range, from rapid hydrolysis at pH 8 to nearly inert at pH 1, and that the Taft parameter of the orthoester substituent allows an adequate prediction of the reaction kinetics. Moreover, the synthesis of an alkyne-capped cryptand enabled the post-functionalization of orthoester cryptands by Sonogashira and CuAAC “click” reactions. The methylation of the resulting triazole furnished a cryptate that was kinetically inert towards orthoester exchange and hydrolysis at pH > 1, which is equivalent to the “turnoff” of constitutionally dynamic imines by means of reduction These findings indicate that orthoester cages may be more broadly useful than anticipated, e.g. as drug delivery agents with precisely tunable biodegradability or, thanks to the kinetic locking strategy, as ion sensors. The experimental process involved the reaction of (Trimethoxymethyl)benzene(cas: 707-07-3).Synthetic Route of 707-07-3

The Article related to self assembled orthoester cryptand preparation degradation kinetics, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.Synthetic Route of 707-07-3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On April 11, 2013, Boss, Christoph; Brotschi, Christine; Heidmann, Bibia; Sifferlen, Thierry; Williams, Jodi T. published a patent.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate The title of the patent was Preparation of diazabicyclononane derivatives for use as orexin receptor antagonists. And the patent contained the following:

Title compounds I [A = (un)substituted Ph or heteroaryl; B = (un)substituted heteroaryl; X = CH2 or O], and their pharmaceutically acceptable salts, are prepared and disclosed as orexin receptor antagonists. Thus, e.g., II was prepared by a multistep procedure (preparation given). I were evaluated in OX1 receptor assays, e.g., II demonstrated an IC50 value of 8 nM. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

The Article related to diazabicyclononane derivative preparation orexin receptor antagonist, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ganesan, Divakar; Chennapuram, Madhu; Begum, Zubeda; Seki, Chigusa; Okuyama, Yuko; Kwon, Eunsang; Uwai, Koji; Tokiwa, Michio; Tokiwa, Suguru; Takeshita, Mitsuhiro; Nakano, Hiroto published an article in 2019, the title of the article was Sugar based γ-amino alcohol organocatalyst for asymmetric michael addition of β-keto esters with nitroolefins.Category: esters-buliding-blocks And the article contains the following content:

Sugar based γ-amino alc. was used in asym. Michael addition of β-keto esters with nitroolefins for the first time affording the corresponding several chiral Michael adducts bearing quaternary chiral carbon center in moderate to good chem. yields and stereoselectivities (up to 98%, up to dr. 95:5, up to 84% ee). The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Category: esters-buliding-blocks

The Article related to sugar amino alc organocatalyst michael addition ketoester nitroolefin, Catalysis, Reaction Kinetics, and Inorganic Reaction Mechanisms: Catalytic Reactions and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 6, 2012, Han, Haitao; Pan, Jianfeng; Jiang, Zhigan; Hu, Tao; Ma, Rujian; Chen, Shuhui published a patent.Application In Synthesis of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate The title of the patent was A process for preparing diazabicyclo[3.3.1]nonane derivatives. And the patent contained the following:

The invention relates to a process for the preparation of diazabicyclo[3.3.1]nonane derivative I, useful as intermediate for manufacturing antiarrhythmic drugs. For instance, the compound I was prepared by heterocyclization of N-Boc-4-oxopiperidine with formaldehyde and benzylamine followed by addition to 1-[(isocyanomethyl)sulfonyl]-4-methyl-benzene, hydrolysis, protection with (Boc)2O, reduction, and protection with CbzCl. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Application In Synthesis of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

The Article related to diazabicyclononane derivative preparation antiarrhythmic intermediate, Heterocyclic Compounds (More Than One Hetero Atom): Eight- and Higher-Membered Rings and other aspects.Application In Synthesis of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 5, 2019, Yebdri, Sihem; Nehar, Oussama; Mahboub, Radia; Roisnel, Thierry; Boukli-Hacene, Leila; Louhibi, Samira published an article.Recommanded Product: Phenyl Salicylate The title of the article was Characterizations of crystalline structure and catalytic activity of zwitterionic imidazole derivatives. And the article contained the following:

The zwitterion ligand L1 has been synthesized and characterized by single-crystal X-ray diffraction, and spectroscopic techniques (1H, 13C NMR, FT-IR, ESI-MS, and UV-Vis). The crystal structure shows that L1 mols. are planar and are connected via intermol. N-H—-O and intramol. N-H—-O interactions. The NMR anal. shows the presence of two mesomeric forms of L1: zwitterion and ketone-imidazolidine. The kinetic study of in situ complexes is followed by UV-vis spectroscopy and revealed a binuclear structure built from square base pyramidal geometry and octahedral one. In situ complexes obtained from L1 with different copper (II) salts are studied for their catecholase activities using 3,5-di-tert-butylcatechol. The obtained 3,5-di-tert-butylquinone was characterized by single-crystal X-ray diffraction,. The results show that the catalytic activity depends on the nature of the metal salt anion. From Michaelis-Menten model, we have evaluated the dissociation constant and the bond constant which are in good agreement with those of literature. The structure-activity relationship show that the high rate of catalytic oxidation depends on the presence of copper ion in the complex. The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).Recommanded Product: Phenyl Salicylate

The Article related to zwitterionic imidazole derivative catalytic activity crystalline structure, Catalysis, Reaction Kinetics, and Inorganic Reaction Mechanisms: Catalytic Reactions and other aspects.Recommanded Product: Phenyl Salicylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics